Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-26

FDA Approved: VALGANCICLOVIR — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved the original ANDA for valganciclovir from Ajanta Pharma USA Inc., establishing a generic antiviral product. It is indicated for CMV infection and C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir (Valganciclovir)

Snippet

ORIG AP for VALGANCICLOVIR (VALGANCICLOVIR)